MMM

3M Company (Minnesota Mining and Manufacturing Company) - 1993 Annual Report Summary

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended December 31, 1993. 3M is an integrated enterprise employing 86,168 people, organized into three business sectors: Industrial and Consumer, Information, Imaging and Electronic, and Life Sciences. The company operates 82 plants in the U.S. and 109 facilities in 44 other countries. 1993 was characterized by global economic recessions in Europe and Japan, negative currency translation effects, and a soft U.S. health care market.

Key Financial Metrics

Note: 1992 Net Income includes a $129 million legal settlement and $115 million in special charges. 1993 Operating Income includes approximately $53 million in rationalization and separation costs.

Material Changes vs. Prior Period

• Sales Growth: Worldwide net sales increased 1.0% to $14.02 billion. U.S. sales rose 3% driven by volume, while international sales fell 1% due to a 6% negative currency translation impact.
• Profitability: Operating income decreased 1.9% to $1.956 billion. The decline was driven by pricing pressures and currency effects, which offset gains from volume and cost control.
• Net Income: Increased 2.5% to $1.263 billion. Currency fluctuations reduced net income by approximately $62 million (29 cents per share).
• Cost Structure: Cost of goods sold as a percentage of sales increased to 60.8% from 60.1%, while Selling, General, and Administrative (SG&A) expenses decreased to 25.2% from 25.6% due to cost-reduction programs.
• Debt: Long-term debt increased to $796 million, largely due to a $469 million guarantee of debt for the Employee Stock Ownership Plan (ESOP).

Guidance, Outlook, and Risks

Outlook: Management expects slightly better global economic growth in 1994, particularly in the second half. However, the pricing environment is expected to remain competitive, and currency fluctuations could negatively impact results. Spending on R&D and capital equipment is expected to remain at 1993 levels. Employment levels are projected to decline slightly in 1994.

Financial Goals: Long-term targets include 10%+ annual earnings per share growth, 20-25% return on stockholders' equity, and 30% of sales from products introduced in the last four years (achieved >25% in 1993).

Risks and Contingencies:

• Mammary Implant Litigation: 3M is a defendant in 3,054 claims involving silicone gel implants. While a global settlement was announced by other defendants in February 1994, 3M was not included. Management believes insurance coverage is sufficient to cover liabilities and costs, posing no material risk.
• Environmental Liabilities: The company is involved in various environmental proceedings regarding waste disposal. Accruals are reviewed quarterly, but future liability amounts cannot be estimated due to legal uncertainties.
• Accounting Changes: Adoption of SFAS No. 112 (Postemployment Benefits) in Q1 1994 is expected to have a diminutive effect on results.

Investor Verification Checklist

• Currency Impact: Verify the sensitivity of future earnings to U.S. dollar strength, as currency translation reduced 1993 net income by $62 million.
• Implant Litigation Status: Monitor ongoing discussions regarding the silicone gel implant claims and the potential for 3M to join a global settlement or face independent liability.
• Health Care Sector Exposure: Assess the impact of U.S. health care reform uncertainty on the Life Sciences sector, which saw operating income decline 8.6% in 1993.
• Share Repurchases: Note the authorization to repurchase up to 12 million shares (pre-split) and the recent 6% dividend increase, signaling management confidence despite economic headwinds.
• Product Mix: Confirm that the target of 30% of sales from new products (introduced in the last 4 years) is being met, as this is a key strategic goal.